Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12,621 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Artificial intelligence-powered spatial analysis of tumor-infiltrating lymphocytes as a biomarker in locally advanced unresectable thymic epithelial neoplasm: A single-center, retrospective, longitudinal cohort study.
Kim DH, Lim Y, Kim S, Ock CY, Youk J, Kim M, Kim TM, Kim DW, Kim HJ, Koh J, Jung KC, Na KJ, Kang CH, Keam B. Kim DH, et al. Among authors: kim hj, kim dw, kim s, kim m, kim tm. Thorac Cancer. 2023 Oct;14(30):3001-3011. doi: 10.1111/1759-7714.15089. Epub 2023 Sep 7. Thorac Cancer. 2023. PMID: 37675597 Free PMC article.
Impact of PIK3CA and cell cycle pathway genetic alterations on durvalumab efficacy in patients with head and neck squamous cell carcinoma: Post hoc analysis of TRIUMPH study.
Kim DH, Lim ST, Kim HR, Kang EJ, Ahn HK, Lee YG, Sun S, Kwon JH, Lee SC, Lee HW, Kim MK, Keam B, Park KU, Shin SH, Yun HJ. Kim DH, et al. Among authors: kim hr, kim mk. Oral Oncol. 2024 Apr;151:106739. doi: 10.1016/j.oraloncology.2024.106739. Epub 2024 Mar 7. Oral Oncol. 2024. PMID: 38458039 Clinical Trial.
12,621 results
You have reached the last available page of results. Please see the User Guide for more information.